Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

Palace Capital Analyst Q&A with Hardman & Co (LON:PCA)

Palace Capital (LON:PCA) is the topic of conversation when Hardman and Co’s Analyst Mike Foster caught up with DirectorsTalk for an exclusive interview. Q1: PCA has reported results, what is..

Non-Standard Finance Analyst Q&A (LON:NSF)

Non-Standard Finance (LON:NSF) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: Non-Standard Finance had a severe share..

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...

Gresham House Strategic MD Q&A with Graham Bird (LON:GHS)

Gresham House Strategic (LON:GHS) Managing Director Graham Bird caught up with DirectorsTalk for an exclusive interview to discuss financial and investment management highlights, post period performance and the outlook for..

Premier Miton Investors Q&A with Head of Equities Gervais Williams (LON:PMI)

Premier Miton Investors (LON:PMI) Head of Equities Gervais Williams caught up with DirectorsTalk for an exclusive interview to discuss Morgan Stanley’s view on UK equities, how attractive the FTSE Small..

Sativa Group Q&A: New appointments, medicinal cannabis licence & admission to AIM (NEX:SATI)

Sativa Group (NEX:SATI) Chief Executive Officer Henry Lees-Buckley caught up with DirectorsTalk for an exclusive interview to discuss the new appointments in the Group, the progress of the cannabis cultivation..

Cambria Automobiles Q&A “Results are very impressive” (LON:CAMB)

Cambria Automobiles (LON:CAMB) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: Cambria Automobiles has released full..

TT Electronics Q&A: Good performance to continue into 2020 (LON:TTG)

TT Electronics (LON:TTG) Chief Executive Officer Richard Tyson caught up with DirectorsTalk for an exclusive interview to discuss the recent trading update, good visibility going forward, the Excelitas acquisition and..

Touchstone Exploration Q&A Production to double from existing production base (LON:TXP)

Touchstone Exploration (LON:TXP) Chief Executive Officer Paul Baay caught up with DirectorsTalk for an exclusive interview to discuss the test results at their COHO well, what’s next on the exploration..

NQ Minerals Q&A with new Chairman David Lenigas (NEX:NQMI)

NQ Minerals (NEX:NQMI) Chairman David Lenigas caught up with DirectorsTalk for an exclusive interview to discuss his new role as Chairman, what investors can expect over the coming months and..

Jubilee Metals Group Q&A “Tremendous growth in earnings” (LON:JLP)

Jubilee Metals Group (LON:JLP) Chief Executive Officer Leon Coetzer caught up with DirectorsTalk for an exclusive interview to discuss their results for the year ended 30 June, growth in earnings..

Advanced Oncotherapy Analyst Q&A with Dr Martin Hall (LON:AVO)

Advanced Oncotherapy (LON:AVO) is the topic of conversation when Hardman and Co’s Head of Life Sciences Dr Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: You recently..

Morses Club Analyst Q&A “Clear customer-demand-driven strategy”

Morses Club (LON:MCL) is the topic of conversation when Hardman and Co’s Financial Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: What lessons did you learn..

Arbuthnot Banking Group Q&A Analyst notes continued strong franchise growth (LON:ARBB)

Arbuthnot Banking Group (LON:ARBB) is the topic of conversation when Hardman and Co’s Financial Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: What did Arbuthnot Banking..

Genedrive Analyst anticipating accelerated news flow (LON:GDR)

Genedrive (LON:GDR) is the topic of conversation when Hardman and Co’s Analyst Dr Dorothea Hill caught up with DirectorsTalk for an exclusive interview. Q1: You recently released a note explaining that..

Q&A with Avacta Group CEO Alastair Smith (LON:AVCT)

Avacta Group (LON:AVCT) Chief Executive Officer Alastair Smith caught up with DirectorsTalk for an exclusive interview to discuss their agreement with ADC Therapeutics, the Phase I AVA6000 trial, commercial opportunities,..

Inchcape Analyst Q&A wth Zeus Capital (LON:INCH)

Inchcape (LON:INCH) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: Inchcape, you’ve just put a new..

Vordere Q&A with CEO Nicholas Hofgren (LON:VOR)

Vordere (LON:VOR) Chief Executive Officer Nicholas Hofgren caught up with DirectorsTalk for an exclusive interview to discuss their latest acquisition in Brazil, the background behind next week’s GM, advice to..

Tatton Asset Management Q&A with Analyst Zeus Capital (LON:TAM)

Tatton Asset Management (LON:TAM) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: Tatton Asset Management has released an update for..

Sativa Group Q&A: Medicinal cannabis controlled drug licence (NEX:SATI)

Sativa Group (NEX:SATI) Chief Executive Officer Henry Lees-Buckley caught up with DirectorsTalk for an exclusive interview to discuss the controlled drug licence awarded by the Home Office. Q1: A news..

Search

Funds

Q & A

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

Q & A

FTSE 100

Funds